Fundraising Fox

Genomind

King of Prussia, US · 2 known investors

genomind.com ↗

Genomind provides pharmacogenetic testing and precision medicine software to help healthcare providers tailor medication prescriptions based on patients' genetic profiles, lifestyle, and environment. The platform integrates genetic data with clinical expertise to reduce adverse drug events and improve treatment outcomes across individual and population health settings.

Digital HealthHealthtechMedical Devicesin /genomind@genomind

Founders & leadership

SH
Stephen HallerExecutive Officer
RW
Rina WolfDirector
RI
Ronald I. DozoretzExecutive Officer, Director, Promoter
MK
Michael KofflerExecutive Officer, Director, Promoter
GN
Gloria NussExecutive Officer
BE
Beth E. DozoretzExecutive Officer, Director
JC
John ChadwickDirector
TS
Theresa SextonDirector
JA
Joseph AntonDirector
TH
Thomas HessExecutive Officer

Investors · 2

Claritas CapitalNashville · $2M – $5M
Claritas HealthcarereportedNashville

Reported raises · per SEC filings

Form D private placements
▶$6.4MraisedApr 2021 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Beth DozoretzDirector
  • Tom HessExecutive Officer
  • Shelloy KigerDirector
  • Stephen HallerExecutive Officer
  • Theresa SextonDirector
  • John ChadwickDirector
  • Shawn Patrick O'BrienExecutive Officer, Director
Offering amount
$21.1M
Amount sold
$6.4M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.6MraisedSep 2020 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen HallerExecutive Officer
  • Thomas HessExecutive Officer
  • Gloria NussExecutive Officer
  • Kip OlmsteadExecutive Officer
  • Brad LucasDirector
  • Shawn P. O'BrienExecutive Officer, Director
  • Theresa SextonDirector
  • John ChadwickDirector
  • Joseph AntonDirector
Offering amount
$21.7M
Amount sold
$20.6M
Minimum investment
$100K
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.8MraisedOct 2017 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Theresa SextonDirector
  • Beth E. DozoretzExecutive Officer, Director
  • Joseph AntonDirector
  • Ronald I. DozoretzExecutive Officer, Director, Promoter
  • Thomas HessExecutive Officer
  • Stephen HallerExecutive Officer
  • Rina WolfDirector
  • Gloria NussExecutive Officer
  • John ChadwickDirector
  • Michael KofflerExecutive Officer, Director, Promoter
Offering amount
$13.8M
Amount sold
$7.8M
Minimum investment
$250K
First sale
Feb 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20.9MraisedJul 2016 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen HallerExecutive Officer
  • Rina WolfDirector
  • Ronald I. DozoretzExecutive Officer, Director, Promoter
  • Michael KofflerExecutive Officer, Director, Promoter
  • Gloria NussExecutive Officer
  • Beth E. DozoretzExecutive Officer, Director
  • John ChadwickDirector
  • Theresa SextonDirector
  • Joseph AntonDirector
  • Thomas HessExecutive Officer
Offering amount
$25.9M
Amount sold
$20.9M
Minimum investment
$200K
First sale
Apr 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.